Alcon Azione

Alcon EBITDA

Il EBITDA (Guadagni prima di interessi, tasse, ammortamenti e svalutazioni) di Alcon (ALC.SW) al 21 mar 2026 è 1,42 miliardi USD. L'anno precedente, EBITDA (Guadagni prima di interessi, tasse, ammortamenti e svalutazioni) era 1,35 miliardi USD — una variazione del 4,51% (superiore).

EBITDA

1,42 miliardiUSD

YoY

4,51%

Ultimo aggiornamento:

EBITDA (Guadagni prima di interessi, tasse, ammortamenti e svalutazioni) di Alcon ammonta a 2026 1,42 miliardi USD. EBITDA (Guadagni prima di interessi, tasse, ammortamenti e svalutazioni) di Alcon ammontava a 2025 1,35 miliardi USD. Diminuisce del 4,51% superiore rispetto all'anno precedente.
Access this data via the Eulerpool API

Alcon Analisi delle Azioni

Cosa fa Alcon? Alcon AG is a leading company in ophthalmology with more than 70 years of experience in this industry. The company was founded in 1945 by Robert Alexander and William Conner and has its headquarters in Geneva, Switzerland. Alcon AG has been part of the Novartis Group since 2019 and is a leader in the production of ophthalmic products. The business model of Alcon AG is based on the manufacturing and sale of ophthalmic products. The company offers medical products such as contact lenses, surgical instruments, eye drops, and intraocular lenses. Alcon AG specializes in the development of products that can be used for various eye diseases. The company provides a wide range of products that can be used by ophthalmologists and opticians. The various divisions of Alcon AG include eye care products, surgical products, and diagnostic products. Eye care products, such as contact lenses, offer consumers a safe and easy way to correct their vision. Surgical products include a wide range of instruments used in eye surgeries. Diagnostic products help identify eye diseases and support treatment. Alcon AG specializes in the development of products for the treatment of eye diseases. These include conditions such as cataracts, glaucoma, and age-related macular degeneration. The company offers various products that can be used for these conditions, such as eye drops to reduce elevated eye pressure in glaucoma. It has also developed a wide range of products for refractive correction, allowing people to improve their vision. Alcon AG works closely with leading ophthalmologists and opticians to optimize its product development. This close collaboration ensures that Alcon AG's products meet the needs of patients and provide them with high safety and effectiveness. With its innovative products and technologies, Alcon AG aims to improve the quality of life for patients and provide them with optimal care and treatment. Overall, Alcon AG is a leading company in ophthalmology, offering its customers a wide range of innovative and high-quality products. From diagnosis to care to surgical interventions, Alcon AG's product range covers all areas of ophthalmology. The company is known for its research and development and is constantly working towards advancing ophthalmology. Through its continuous innovation and customer orientation, Alcon AG has established a strong position in the healthcare industry and will continue to introduce new products and technologies in the future. Alcon è una delle aziende più popolari su Eulerpool.com.

Domande frequenti su Alcon azioni

Il EBITDA (Guadagni prima di interessi, tasse, ammortamenti e svalutazioni) di Alcon ammontava a 1,35 miliardi USD 1,42 miliardi

Access this data via the Eulerpool API

Conto economico — Alcon

I piani di risparmio azionario offrono un modo attraente per gli investitori di costruire ricchezza a lungo termine. Uno dei principali vantaggi è il cosiddetto effetto media del costo: investendo regolarmente un importo fisso in azioni o fondi azionari, si acquistano automaticamente più quote quando i prezzi sono bassi e meno quando sono alti. Ciò può portare a un prezzo medio per azione più favorevole nel tempo. Inoltre, i piani di risparmio azionario consentono anche ai piccoli investitori l'accesso a azioni costose, poiché possono partecipare già con piccoli importi. L'investimento regolare promuove inoltre una strategia di investimento disciplinata e aiuta a evitare decisioni emotive, come acquisti o vendite impulsivi. Inoltre, gli investitori beneficiano dell'apprezzamento potenziale delle azioni e delle distribuzioni di dividendi, che possono essere reinvestite, migliorando l'effetto composito e quindi la crescita del capitale investito.

Tutte le Metriche Finanziarie — Alcon